Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Clin Pharmacol Ther ; 86(3): 336-9, 2009 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-19571803

RESUMEN

It has been more than 60 years since Alexander Fleming discovered the drug that came to be known as penicillin. Antibiotics are now one of the most frequently used medications in the United States and are prescribed by medical professionals in almost every specialty. The past decade has seen an alarming increase in the number of pathogens that are resistant to antimicrobial drugs, in the hospital as well as in the community.(1) Among the gram-positive pathogens, methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus species are the biggest threats. The situation is even more alarming with respect to gram-negative pathogens, especially because there are currently no late clinical trials involving new anti-infective drugs that are active against these pathogens.


Asunto(s)
Antiinfecciosos/farmacología , Farmacorresistencia Microbiana , Antiinfecciosos/metabolismo , Antiinfecciosos/uso terapéutico , Proteínas Bacterianas/metabolismo , Carbapenémicos/farmacología , Resistencia a Múltiples Medicamentos , Humanos , Control de Infecciones , Infecciones/transmisión , Staphylococcus aureus Resistente a Meticilina/efectos de los fármacos , beta-Lactamasas/genética , beta-Lactamasas/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA